For clinics and prescribers

Show the paperwork behind what you dispense. Identify and notify reachable patients if a lot is recalled.

You dispense compounded medicine you did not make. If a lot is recalled, you have no way to reach the patients who received it, and no documentation record to show them. Veritura notifies the patients who saved their vial, hands you the order list for the rest, and gives you the record to show any of them.

The problem

You dispense compounded medicine you did not make.

The patient trusts your name on it, but you cannot show them the documentation behind it, because it lives with the compounder, if it exists at all.

And if that lot is ever recalled, you have no way to reach the specific patients who received it. The net everyone assumes is there simply is not.

Veritura gives you a record to show the patient, and a way to notify the reachable patients if a lot is recalled, with the call list for everyone it cannot address.

How it works for you

Three steps, then it runs itself.

  1. 01

    Show the proof

    Hand the patient their exact lot's independently checked documentation.

  2. 02

    Watch every lot

    Everything you received stays matched against live FDA recalls, automatically.

  3. 03

    Reach the patients it can

    If a lot is recalled, Veritura notifies the patients who saved their vial, PHI-free, and returns the order list for the ones only you can call.

Screening one order against your policy.

One order or lot is read against the policy the customer wrote, and the decision comes back Allow, Review or Hold with every reason naming the rule that fired.

You set the bar once, from three presets.

  • Strict

    Everything must be complete, current and human-reviewed; any hard signal holds; a supplier with no qualification file at all is a hard hold rather than a soft review.

  • Standard

    Cleared lot, current file, no hard signals. Gaps drop to review rather than hold.

  • Lenient

    Only the hardest public-record signals hold; everything else allows.

All three re-run automatically when new evidence arrives. Only Strict withholds the release: Standard and Lenient release a passport the moment the policy allows it, Strict keeps that click with a person.

  1. Your policy

    An order is screened, a check is saved, or a shipment is received.

    ClearGate evaluates. When the policy has auto-decide on, no one has to click Run; the trigger is recorded but the record produced is identical to a manual run.

    Record state: Evaluation started
  2. Engine

    Evaluation started.

    The supplier qualification file and the lot are read against the policy. Hold beats review beats allow. Every reason carries the policy rule code that produced it.

  3. Engine

    A decision exists.

    The decision is signed and hash-chained to the one before it, with the policy version pinned inside the record.

    Record state: Signed decision on the chain
  4. Engine

    The decision is stored.

    A hold stamps clearGateHold on the lot, which blocks the passport on its own. A later allow or review clears that hold; the signed record itself is never mutated.

    Record state: clearGateHold set or lifted

One decision comes back

  • ClearGate decision: Allow

    Meets your policy

    No hold rule and no review rule fired.

  • ClearGate decision: Review

    Needs review

    At least one review rule fired and no hold rule did.

  • ClearGate decision: Hold

    Does not meet policy

    At least one hold rule fired.

Someone questions a decision. The stored evidence and the pinned policy snapshot are fed back through the same evaluator. A correct decision replays to the identical decision, label and reasons.

ClearGate reports documentation conformance against the policy the customer wrote. The customer owns the policy; Veritura owns the verification. A decision is never a product pass, a safety statement, or an approval.

What suits you

Every feature closes a gap you have today.

  • Screen a supplier before you buy

    Choosing a compounder on a sales call is choosing blind. Veritura lets you check a source's sourcing and see a recent passport before you order.

    De-risk the purchase at the moment you spend.

  • Inbound portfolio

    The lots you received live in a dozen inboxes and packing slips. Veritura keeps them in one place, watched.

    Always current, without a spreadsheet.

  • Continuous supplier monitoring

    A supplier's standing can change the week after you buy from them. Veritura re-checks every source you use against live FDA enforcement, on its own.

    A supplier's trouble reaches you as an alert, not a surprise.

  • Check the FDA lists first

    Before you even open an account, you can check whether a substance is on the FDA lists that govern whether it can be compounded.

    A free first look, no account, no card.

Evidence Passport per lot

"Is this real?" is not a question you can answer with a shrug.

Veritura shows the patient their exact lot's independently checked documentation. Trust that closes the visit and keeps the patient.

Sample workspace · not a live account

Evidence Passport

Semaglutide (base) API

V-SBX-00013

Evidence posture

Evidence posture: Clear

The document set met the configured policy. It describes the paperwork, not the medicine.

Certificate of analysis

Source-confirmed

The issuing laboratory confirmed issuance through the recorded verification route.

Order
PO-DEMO-0413
Lot
LOT-7741-A
Supplier
Aurora Pharma Supply
Quantity
250 g
Received
July 22, 2026
Released
July 23, 2026
Passport issued
July 23, 2026
Methodology
v1.0 · April 30, 2026

Documents on file

6

  • Certificate of analysis

    COA-7741-A.pdf · Issuing laboratory confirmed issuance through the recorded route

    Source-confirmed
  • Certificate of conformance

    CoC-7741.pdf · Required identity, lot, and date fields present

    Veritura evaluated
  • Safety data sheet

    SDS-SEMA-04.pdf · Current revision on file

    Veritura evaluated
  • GMP certificate

    GMP-AUR-2026.pdf · Supplied by the operator

    Operator attested
  • Receiving inspection

    Recorded in workspace · Container and label checked at receipt

    Operator attested
  • Shipment label

    LBL-7741-A.jpg · Lot identifier matches the certificate of analysis

    Veritura evaluated

What this record does not establish

  • Documentation diligence only. No product was tested and no supplier was approved.
  • Absence of a public-source match is not proof of absence.
  • Produced under methodology v1.0, April 30, 2026.

Boundary

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.

Recall net

A recall that reaches the pharmacy but never the patient is not a recall that worked.

Veritura maps a recalled lot to every released record that put it in a patient's hands, PHI-free through the vial. The patients who saved their vial are notified directly, every other order comes back as a call list for you, and each of those passport pages flips to recalled the moment the recall is declared. Something no compounder or pharmacy system can do.

Sample workspace · not a live account

Living Supply Shield

Alerts

3 open · 4 in the last 7 days
  • Action needed

    Verification route unreachable

    2 hours ago

    BlueRiver API Co · the published verify link for LOT-BR-0816 did not answer on three attempts. A corrected source route has been requested.

    MON-DEMO-181 supplier · 1 lot · 1 order

  • Attention

    Sterility scope gap on an open lot

    9 hours ago

    Keystone Peptide Labs · LOT-KP-2407 carries no sterility or endotoxin result. Missing evidence is not a failed test; the lot stays in review until it lands.

    MON-DEMO-211 supplier · 1 lot

  • Informational

    Public-source snapshot refreshed

    Yesterday

    openFDA enforcement and recall records re-captured for 4 suppliers. No match in the captured sources. Disposition unchanged.

    MON-DEMO-174 suppliers

  • Attention

    Qualification element falls due

    2 days ago

    Aurora Pharma Supply · ongoing review is due July 30, 2026. Five of six elements remain on file with current dates.

    MON-DEMO-221 supplier

A monitoring signal maps a captured public record to the suppliers, lots, and orders it touches. It never changes a disposition on its own, and no match in a captured source is not proof of absence.

What you can skip

The API-sourcing desk is not yours.

You do not run a receiving dock or a cGMP line, so the API-sourcing desk is not yours. This is the documentation layer for the compounded medicine you dispense but did not make. One plan boundary belongs here too: Clinic Starter at $49 per month is document review and the evidence record only. Passport production, supplier monitoring, supplier files, and the recall workflow start on the Clinic plan at $99 per month, and production Passports meter at $3 per order on top.

Boundary

Veritura does not test medicine, approve suppliers, recommend purchases, or make medical, legal, product-safety, or FDA-approval determinations. There is no paid or subjective placement: suppliers cannot pay for a better result or a better position, no listing fee, no subscription, and no pay-to-rank. Where results are ordered rather than filtered, the order is set by a published documentation-coverage grade, and that grade is never a recommendation, a preference, or a statement about any product.

See it on your own documents.

Independent documentation diligence. No safety, quality, legal, or FDA-approval claims.